Y. Hirabayashi

发表

H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin.

T. Nagamine, T. Kurata, S. Tamura, 1991, Immunology.

Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.

T. Nagamine, Y. Ito, T. Kurata, 1992, Journal of immunology.

Superior cross‐protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

T. Kurata, S. Tamura, H. Asanuma, 1992, European journal of immunology.

Quantitative estimation of human immunodeficiency virus type-1 provirus in CD4+ T lymphocytes using the polymerase chain reaction.

S. Oka, K. Shimada, S. Kimura, 1991, Molecular and cellular probes.

Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.

T. Nagamine, T. Kurata, S. Tamura, 1990, Vaccine.

Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.

T. Nagamine, T. Kurata, S. Tamura, 1990, Vaccine.

Involvement of antigen-presenting cells in the enhancement of the in vitro antibody responses by cholera toxin B subunit.

S. Tamura, K. Shimada, Y. Hirabayashi, 1992, Immunology.

Cross‐protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules

T. Nagamine, T. Kurata, S. Tamura, 1991, European journal of immunology.

A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S.

S. Oka, N. Tachikawa, H. Gatanaga, 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

A randomized trial of reduced doses of azidothymidine in Japanese patients with human immunodeficiency virus type 1 infection.

S. Oka, Y. Kikuchi, K. Shimada, 1992, Internal medicine.

[The first imported case of Lassa fever in Japan].

S. Oka, J. McCormick, S. Fisher-Hoch, 1989, Nihon rinsho. Japanese journal of clinical medicine.

Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography.

S. Oka, K. Tsuchiya, S. Kimura, 2006, Biomedical chromatography : BMC.

Rapid and Simple Phenotypic Assay for Drug Susceptibility of Human Immunodeficiency Virus Type 1 Using CCR5-Expressing HeLa/CD4+ Cell Clone 1-10 (MAGIC-5)

S. Oka, A. Kojima, A. Hachiya, 2001, Antimicrobial Agents and Chemotherapy.

Sustained cytomegalovirus-specific CD4+ T cell response associated with prevention of recurrence of cytomegalovirus retinitis without secondary prophylaxis after highly active antiretroviral therapy in patients with AIDS.

S. Oka, N. Tachikawa, K. Teruya, 2001, AIDS research and human retroviruses.

Amplification and detection of a single molecule of human immunodeficiency virus RNA

Taro Yamamoto, S. Katamine, T. Miyamoto, 1993, Virus Genes.

An imported case of Lassa fever with late appearance of polyserositis.

S. Oka, J. McCormick, S. Fisher-Hoch, 1988, The Journal of infectious diseases.

Quantitative analysis of human immunodeficiency virus type-1 DNA in asymptomatic carriers using the polymerase chain reaction.

S. Oka, K. Shimada, S. Kimura, 1990, Biochemical and biophysical research communications.

Cross-protection against influenza B type virus infection by intranasal inoculation of the HA vaccines combined with cholera toxin B subunit.

T. Nagamine, T. Kurata, C. Aizawa, 1990, Vaccine.